Replies to post #182791 on SMART MONEY GROUP

[BlazingStocks]

$NBIO - Management highlights the research as corroborating its own sense that Pritumumab (PTB) is a potential breakthrough therapy in the $1.8 billion underserved brain cancer market.
https://finance.yahoo.com/news/nascent-biotech-receives-analyst-opinion-130000256.html